Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.60 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.60 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.60 |
| ▸ | MEN1 | O00255 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | APEX1 | P27695 | 3/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | ACHE | P22303 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.54 |
| ▸ | PPARG | P37231 | 7/20 | 0.54 |
| ▸ | PPARD | Q03181 | 7/20 | 0.54 |
| ▸ | PPARA | Q07869 | 7/20 | 0.54 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.54 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5535076 | 1.00 | TSHR (0.60) | TSHRLMNANFKB1PMP22MEN1 | |
| SCHEMBL5538773 | 1.00 | TSHR (0.60) | TSHRLMNANFKB1PMP22MEN1 | |
| SCHEMBL5533890 | 1.00 | TSHR (0.60) | TSHRLMNANFKB1PMP22MEN1 | |
| SCHEMBL5538795 | 1.00 | TSHR (0.60) | TSHRLMNANFKB1PMP22MEN1 | |
| SCHEMBL5535235 | 1.00 | TSHR (0.60) | TSHRLMNANFKB1PMP22MEN1 | |
| SCHEMBL5535756 | 1.00 | TSHR (0.60) | TSHRLMNANFKB1PMP22MEN1 | |
| SCHEMBL5533537 | 1.00 | TSHR (0.60) | TSHRLMNANFKB1PMP22MEN1 | |
| SCHEMBL5533709 | 1.00 | TSHR (0.60) | TSHRLMNANFKB1PMP22MEN1 | |
| SCHEMBL5532639 | 1.00 | TSHR (0.60) | TSHRLMNANFKB1PMP22MEN1 | |
| SCHEMBL5538389 | 1.00 | TSHR (0.60) | TSHRLMNANFKB1PMP22MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4482988-B1 | PROCESS FOR LIMING OF HIDES, SKINS OR PELTS | STAHL INT B V (NL) | 2025-11-05 | — | — | EP | disclosed |
| US-20250188551-A1 | PROCESS FOR LIMING OF HIDES, SKINS OR PELTS | STAHL INTERNATIONAL B.V. (NL) | 2025-06-12 | — | — | US | disclosed |
| EP-4482988-A1 | PROCESS FOR LIMING OF HIDES, SKINS OR PELTS | Stahl International B.V. (NL) | 2025-01-01 | — | — | EP | disclosed |
| WO-2023163594-A1 | PROCESS FOR LIMING OF HIDES, SKINS OR PELTS | STAHL INTERNATIONAL B.V. (NL) | 2023-08-31 | — | — | WO | disclosed |
| US-20230159592-A1 | PCSK9 ANTAGONIST COMPOUNDS | MERCK SHARP & DOHME LLC | 2023-05-25 | — | — | US | disclosed |
| WO-2020113213-A2 | CYCLIC PANTETHEINE DERIVATIVES AND USES THEREOF | COMET THERAPEUTICS, INC. (US) | 2020-06-04 | — | — | WO | disclosed |
| US-20070044831-A1 | Electrolyte composition and dye-sensitized solar cell | NATIONAL UNIVERSITY CORPORATION KYUSHU INSTITUTE OF TECHNOLOGY (JP) | 2007-03-01 | — | — | US | disclosed |
| US-20050153938-A1 | Polyphosphonate derivatives for toothpaste compositions | UNIVERSITE D'ANGERS (FR) | 2005-07-14 | — | — | US | disclosed |
| EP-1141136-B1 | A POLYMER/CLAY NANOCOMPOSITE COMPRISING A FUNCTIONALIZED POLYMER OR OLIGOMER AND A PROCESS FOR PREPARING SAME | UNIV SOUTH CAROLINA RES FOUND (US) | 2003-08-20 | — | — | EP | disclosed |
| US-20020137834-A1 | Polymer/clay nanocomposite comprising a functionalized polymer or oligomer and a process for preparing same | EASTMAN CHEMICAL COMPANY | 2002-09-26 | — | — | US | disclosed |
| US-6384121-B1 | POLYMER-CLAY NANOCOMPOSITE COMPRISING MELT-PROCESSIBLE MATRIX POLYMER, LAYERED CLAY MATERIAL, AND MATRIX POLYMER-COMPATIBLE OLIGOMER OR POLYMER HAVING ONIUM FUNCTIONAL GROUP BONDED THERETO | EASTMAN CHEMICAL COMPANY | 2002-05-07 | — | — | US | disclosed |
| EP-1141136-A1 | A POLYMER/CLAY NANOCOMPOSITE COMPRISING A FUNCTIONALIZED POLYMER OR OLIGOMER AND A PROCESS FOR PREPARING SAME | EASTMAN CHEMICAL COMPANY (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000034393-A1 | A POLYMER/CLAY NANOCOMPOSITE COMPRISING A FUNCTIONALIZED POLYMER OR OLIGOMER AND A PROCESS FOR PREPARING SAME | EASTMAN CHEMICAL COMPANY (US) | 2000-06-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159592-A1 | PCSK9 ANTAGONIST COMPOUNDS | PCSK9, PCSK7, PCSK6 | TSHR 531/4885LMNA 867/4885NFKB1 828/4885 |
| US-20050153938-A1 | Polyphosphonate derivatives for toothpaste compositions | DCTPP1, PHOSPHO1, DCPS | TSHR 4752/4885LMNA 4187/4885NFKB1 1582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.